{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:19:16Z","timestamp":1791497956403,"version":"4.3.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010227","name":"Medical Science and Technology Development Foundation, Nanjing Municipality Health Bureau","doi-asserted-by":"publisher","award":["YKK20061"],"award-info":[{"award-number":["YKK20061"]}],"id":[{"id":"10.13039\/501100010227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82101417"],"award-info":[{"award-number":["82101417"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82130036"],"award-info":[{"award-number":["82130036"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2022ZD0211800"],"award-info":[{"award-number":["2022ZD0211800"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81920108017"],"award-info":[{"award-number":["81920108017"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.intimp.2025.114687","type":"journal-article","created":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T16:49:21Z","timestamp":1745081361000},"page":"114687","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Broxyquinoline targets NLRP3 to inhibit inflammasome activation and alleviate NLRP3-associated inflammatory diseases"],"prefix":"10.1016","volume":"156","author":[{"given":"Huaiping","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunshu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen-Lin","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2025.114687_bb0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nri1997","article-title":"Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation","volume":"7","author":"Mariathasan","year":"2007","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2025.114687_bb0010","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2025.114687_bb0015","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"7081","key":"10.1016\/j.intimp.2025.114687_bb0020","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.intimp.2025.114687_bb0025","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1136\/gut.2009.197822","article-title":"Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome","volume":"59","author":"Bauer","year":"2010","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.intimp.2025.114687_bb0030","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s10753-023-01795-5","article-title":"Therapeutic potential of targeting the NLRP3 Inflammasome in rheumatoid arthritis","volume":"46","author":"Gao","year":"2023","journal-title":"Inflammation"},{"issue":"26","key":"10.1016\/j.intimp.2025.114687_bb0035","doi-asserted-by":"crossref","first-page":"10480","DOI":"10.1073\/pnas.1201836109","article-title":"NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis","volume":"109","author":"Inoue","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7434","key":"10.1016\/j.intimp.2025.114687_bb0040","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.intimp.2025.114687_bb0045","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ni.1935","article-title":"Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1\u03b2 in type 2 diabetes","volume":"11","author":"Masters","year":"2010","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2025.114687_bb0050","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.intimp.2025.114687_bb0055","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","article-title":"MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition","volume":"15","author":"Coll","year":"2019","journal-title":"Nat. Chem. Biol."},{"issue":"5","key":"10.1016\/j.intimp.2025.114687_bb0060","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","article-title":"NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice","volume":"66","author":"Mridha","year":"2017","journal-title":"J. Hepatol."},{"issue":"11","key":"10.1016\/j.intimp.2025.114687_bb0065","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1007\/s00221-020-05916-6","article-title":"Protection of MCC950 against Alzheimer\u2019s disease via inhibiting neuronal pyroptosis in SAMP8 mice","volume":"238","author":"Li","year":"2020","journal-title":"Exp. Brain Res."},{"issue":"1","key":"10.1016\/j.intimp.2025.114687_bb0070","doi-asserted-by":"crossref","first-page":"8618","DOI":"10.1038\/s41598-018-26775-w","article-title":"MCC950, a specific small molecule inhibitor of NLRP3 inflammasome attenuates colonic inflammation in spontaneous colitis mice","volume":"8","author":"Perera","year":"2018","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.intimp.2025.114687_bb0075","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1084\/jem.20171419","article-title":"Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders","volume":"214","author":"Jiang","year":"2017","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.intimp.2025.114687_bb0080","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708689","article-title":"Tranilast directly targets NLRP3 to treat inflammasome-driven diseases","volume":"10","author":"Huang","year":"2018","journal-title":"EMBO Mol. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.114687_bb0085","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1038\/s41467-018-04947-6","article-title":"Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity","volume":"9","author":"He","year":"2018","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.intimp.2025.114687_bb0090","doi-asserted-by":"crossref","first-page":"E1530","DOI":"10.1073\/pnas.1716095115","article-title":"OLT1177, a \u03b2-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation","volume":"115","author":"Marchetti","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2025.114687_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175156","article-title":"Ciclopirox inhibits NLRP3 inflammasome activation via protecting mitochondria and ameliorates imiquimod-induced psoriatic inflammation in mice","volume":"930","author":"Liang","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2025.114687_bb0100","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.freeradbiomed.2020.03.007","article-title":"Disulfiram suppresses NLRP3 inflammasome activation to treat peritoneal and gouty inflammation","volume":"152","author":"Deng","year":"2020","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.intimp.2025.114687_bb0105","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nm.3804","article-title":"The ketone metabolite \u03b2-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease","volume":"21","author":"Youm","year":"2015","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.intimp.2025.114687_bb0110","article-title":"In vitro sensitivity of trichomonas vaginalis and Candida albicans to chemotherapeutic agents","volume":"86b","author":"L\u00f6vgren","year":"1978","journal-title":"Acta Pathol. Microbiol. Scand. B"},{"issue":"3","key":"10.1016\/j.intimp.2025.114687_bb0115","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/jac\/dkr516","article-title":"Novel anti-Cryptosporidium activity of known drugs identified by high-throughput screening against parasite fatty acyl-CoA binding protein (ACBP)","volume":"67","author":"Fritzler","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"issue":"4","key":"10.1016\/j.intimp.2025.114687_bb0120","article-title":"Broad susceptibility of Candida auris strains to 8-hydroxyquinolines and mechanisms of resistance","volume":"14","author":"Lohse","year":"2023","journal-title":"mBio"},{"issue":"12","key":"10.1016\/j.intimp.2025.114687_bb0125","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1248\/bpb.b12-00507","article-title":"Effects of clioquinol analogues on the hypoxia-inducible factor pathway and intracelullar mobilization of metal ions","volume":"35","author":"Kim","year":"2012","journal-title":"Biol. Pharm. Bull."},{"issue":"8","key":"10.1016\/j.intimp.2025.114687_bb0130","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1021\/acssynbio.2c00205","article-title":"Discovery of 8-Hydroxyquinoline as a histamine receptor 2 blocker scaffold","volume":"11","author":"Marquez-Gomez","year":"2022","journal-title":"ACS Synth. Biol."},{"issue":"268","key":"10.1016\/j.intimp.2025.114687_bb0135","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF02753081","article-title":"Broxyquinoline and brobenzoxalidine suspension (Intestopan-AI 307) in childhood diarrhoea. A clinical trial on 533 children","volume":"37","author":"Manchanda","year":"1970","journal-title":"Indian J. Pediatr."},{"issue":"4","key":"10.1016\/j.intimp.2025.114687_bb0140","first-page":"505","article-title":"Therapeutic trial of a combination of broxyquinoline and brobenzoxaldine in the treatment of leprosy","volume":"51","author":"Hazra","year":"1979","journal-title":"Lepr. India"},{"issue":"302","key":"10.1016\/j.intimp.2025.114687_bb0145","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF02753456","article-title":"A clinical trial of broxyquinoline--brobenzoxalidine in childhood diarrhoea","volume":"40","author":"Shah","year":"1973","journal-title":"Indian J. Pediatr."},{"issue":"7","key":"10.1016\/j.intimp.2025.114687_bb0150","first-page":"587","article-title":"Comparative study of the efficacy of chloramphenicol and a combination of chloramphenicol, broxyquinoline and brobanzoxaldine in the treatment of enteric fever","volume":"12","author":"Edibam","year":"1975","journal-title":"Indian Pediatr."},{"issue":"4","key":"10.1016\/j.intimp.2025.114687_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/v11040385","article-title":"Screening of an FDA-approved drug library with a two-tier system identifies an entry inhibitor of severe fever with thrombocytopenia syndrome virus","volume":"11","author":"Yuan","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.intimp.2025.114687_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2023.105565","article-title":"Identification of D359-0396 as a novel inhibitor of the activation of NLRP3 inflammasome","volume":"169","author":"Li","year":"2023","journal-title":"Neurochem. Int."},{"issue":"7590","key":"10.1016\/j.intimp.2025.114687_bb0165","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/nature16959","article-title":"NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux","volume":"530","author":"He","year":"2016","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.intimp.2025.114687_bb0170","doi-asserted-by":"crossref","first-page":"974","DOI":"10.4049\/jimmunol.0904145","article-title":"NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses","volume":"185","author":"Gris","year":"2010","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2025.114687_bb0175","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nrd.2018.97","article-title":"Targeting the NLRP3 inflammasome in inflammatory diseases","volume":"17","author":"Mangan","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"8","key":"10.1016\/j.intimp.2025.114687_bb0180","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.tips.2022.04.003","article-title":"NLRP3 and pyroptosis blockers for treating inflammatory diseases","volume":"43","author":"Coll","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"issue":"12","key":"10.1016\/j.intimp.2025.114687_bb0185","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/bph.16036","article-title":"Discovery of alantolactone as a naturally occurring NLRP3 inhibitor to alleviate NLRP3-driven inflammatory diseases in mice","volume":"180","author":"Li","year":"2023","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.intimp.2025.114687_bb0190","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s00018-023-04881-x","article-title":"Discovery of a selective NLRP3-targeting compound with therapeutic activity in MSU-induced peritonitis and DSS-induced acute intestinal inflammation","volume":"80","author":"Zhou","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"issue":"12","key":"10.1016\/j.intimp.2025.114687_bb0195","article-title":"Entrectinib inhibits NLRP3 inflammasome and inflammatory diseases by directly targeting NEK7","volume":"4","author":"Jin","year":"2023","journal-title":"Cell Rep. Med."},{"issue":"9","key":"10.1016\/j.intimp.2025.114687_bb0200","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1056\/NEJMra052130","article-title":"Multiple sclerosis--the plaque and its pathogenesis","volume":"354","author":"Frohman","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.intimp.2025.114687_bb0205","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1038\/s41401-021-00613-8","article-title":"1,2,4-Trimethoxybenzene selectively inhibits NLRP3 inflammasome activation and attenuates experimental autoimmune encephalomyelitis","volume":"42","author":"Pan","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.intimp.2025.114687_bb0210","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","article-title":"Multiple sclerosis","volume":"4","author":"Filippi","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.intimp.2025.114687_bb0215","doi-asserted-by":"crossref","first-page":"14674","DOI":"10.1038\/srep14674","article-title":"IL-1\u03b2 promotes Th17 differentiation by inducing alternative splicing of FOXP3","volume":"5","author":"Mailer","year":"2015","journal-title":"Sci. Rep."}],"updated-by":[{"DOI":"10.1016\/j.intimp.2025.115915","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:00:00Z","timestamp":1763769600000}},{"DOI":"10.1016\/j.intimp.2025.115915","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000}}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925006770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925006770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:58:26Z","timestamp":1778619506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925006770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":43,"alternative-id":["S1567576925006770"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114687","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Broxyquinoline targets NLRP3 to inhibit inflammasome activation and alleviate NLRP3-associated inflammatory diseases","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114687","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114687"}}